Evidence map›Paper›PMID 29128300›Full record

Trial reportLancet (London, England)2018

Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).

Jean Reignier, Julie Boisramé-Helms, Laurent Brisard, Jean-Baptiste Lascarrou, Ali Ait Hssain, Nadia Anguel, Laurent Argaud, Karim Asehnoune, Pierre Asfar, Frédéric Bellec and 38 more

3 registry-linked trialsAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 217 papers, 19 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
217citing papers in PubMed, 19 pooled it
31.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01802099 nacompletednot on this map

Impact of Early Enteral vs. Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines: Multicenter, Randomized Controlled Trial (NUTRIREA-2)

TypeinterventionalSponsorCentre Hospitalier Departemental VendeeRan2013 to 2015Enrolled2,410ConditionsAcute Respiratory Failure, ShockArmsEnteral nutrition, Parenteral nutrition
NCT03699371 naunknown statusnot on this map

Influence of Early vs Late Supplemental ParenteraL Nutrition on Long-term Quality of Life in ICU Patients After Gastrointestinal Oncological Surgery. A Prospective, Randomised, Multi-centre Assessor-blinded Study. hELPLiNe Trial

TypeinterventionalSponsorMedical University of LublinRan2018 to 2021Enrolled220ConditionsNutrition Aspect of CancerArmsEarly Supplemental Parenteral Nutrition
NCT05998902 phase3completednot on this mapstarted 2023, after this paper: background citation

Trophic Enteral Feeding Combined With Supplemental Parenteral Nutrition Treatment in Patients With Severe Stroke (OPENS-2): a Multicentre, Prospective, Randomised, Open-label, Blinded-endpoint Trial

TypeinterventionalSponsorWen Jiang-3Ran2023 to 2026Enrolled546ConditionsSevere Stroke, Acute Stroke, DysphagiaArmsTrophic enteral feeding combined with supplemental parenteral nutrition, Full enteral feeding
3 · Its place in the literature

Who cites it

217 citing papers in PubMed, 19 syntheses or guidelines pooled it, 554 citations in OpenAlex.

  1. Pooled it
  2. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Guideline
  16. Pooled it
  17. Pooled it
  18. [S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2020
    Guideline
  19. Pooled it
  20. Trial

157 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

48 authors at 20 institutions in 1 country.

Jean ReignierMédecine Intensive Réanimation, CHU de Nantes, Nantes, France; Université de Nantes, Nantes, France. Electronic address: jean.reignier@chu-nantes.fr.
Julie Boisramé-HelmsEA 7293, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de Médecine, Université de Strasbourg, Strasbourg, France; Medical Intensive Care Unit, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Laurent BrisardCHU de Nantes, Hôpital Laennec, Département d'Anesthésie et Réanimation, Nantes, France.
Jean-Baptiste LascarrouMédecine Intensive Réanimation, CHU de Nantes, Nantes, France; Université de Nantes, Nantes, France.
Ali Ait HssainMedical Intensive Care Unit, Hôpital Gabriel Montpied, CHU de Clermont-Ferrand, Clermont-Ferrand, France.
Nadia AnguelMedical Intensive Care Unit, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin-Bicêtre, France.
Laurent ArgaudMedical Intensive Care Unit, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.
Karim AsehnouneSurgical Intensive Care Unit, Hotel Dieu, CHU de Nantes, Nantes, France; Université de Nantes, Nantes, France.
Pierre AsfarMedical Intensive Care and Hyperbaric Oxygen Therapy Unit, Centre Hospitalier Universitaire Angers, Angers, France; Laboratoire de Biologie Neurovasculaire et Mitochondriale Intégrée, CNRS UMR 6214 - INSERM U1083, Université Angers, UBL, Angers, France.
Frédéric BellecMedical-Surgical Intensive Care Unit, Centre Hospitalier de Montauban, Montauban, France.
Vlad BotocMedical-Surgical Intensive Care Unit, Centre Hospitalier de Saint-Malo, Saint-Malo, France.
Anne BretagnolMedical Intensive Care Unit, CHR Orléans, Orléans, France.
Hoang-Nam BuiMedical Intensive Care Unit, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
Emmanuel CanetMedical Intensive Care Unit, Saint Louis University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Daniel Da SilvaMedical-Surgical Intensive Care Unit, Centre Hospitalier de Saint-Denis, Saint-Denis, France.
Michael DarmonMedical-Surgical Intensive Care Unit, University Hospital, Saint Etienne, France.
Vincent DasMedical-Surgical Intensive Care Unit, Centre Hospitalier Intercommunal André Grégoire, Montreuil, France.
Jérôme DevaquetMedical-Surgical Intensive Care Unit, Hôpital Foch, Suresnes, France.
Michel DjibreMedical-Surgical Intensive Care Unit, Tenon University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Frédérique GansterMedical Intensive Care Unit, Hôpital Emile Muller, Mulhouse, France.
Maité Garrouste-OrgeasUMR 1137, IAME Team 5, Decision Sciences in Infectious Diseases (DeSCID), Control and Care, Sorbonne Paris Cité, Inserm-Paris Diderot University, Paris, France; Medical-Surgical Unit, Hôpital Saint-Joseph, Paris France; Medical Unit and Palliative Research Group, French and British Institute, Levallois-Perret, France; OUTCOMEREA Research Group, Drancy, France.
Stéphane GaudryMedical-Surgical Intensive Care Unit, Hôpital Louis Mourier, Assistance Publique-Hôpitaux de Paris (AP-HP), Colombes, France; Université Paris Diderot, ECEVE, UMR 1123, Sorbonne Paris Cité, Paris, France.
Olivier GontierMedical-Surgical Intensive Care Unit, Hôpital de Chartres, Chartres, France.
Claude GuérinMedical Intensive Care Unit, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France; Université de Lyon, IMRB INSERM 955, Lyon, France.
Bertrand GuidetMedical Intensive Care Unit, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Sorbonne Université, UPMC Université Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: Epidémiologie Hospitalière Qualité et Organisation des Soins, Paris, France.
Christophe GuittonMedical-Surgical Intensive Care Unit, Hôpital du Mans, Le Mans, France.
Jean-Etienne HerbrechtMedical Intensive Care Unit, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Faculté de Médecine U1121, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
Jean-Claude LacheradeMédecine Intensive Réanimation, Centre Hospitalier Départemental de la Vendée, La Roche sur Yon, France.
Philippe LetocartMedical-Surgical Intensive Care Unit, Hôpital Jacques Puel, Rodez, France.
Frédéric MartinoMedical-Surgical Intensive Care Unit, CHU de Pointe-à-Pitre, Pointe-à-Pitre, France.
Virginie MaximeMedical-Surgical Intensive Care Unit, Hôpital Raymond Poincaré, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France.
Emmanuelle MercierMédecine Intensive Réanimation, Hôpital Bretonneau, CHU Tours, Tours, France.
Jean-Paul MiraMedical Intensive Care Unit, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Saad NseirMedical Intensive Care Unit, CHU Lille, Lille, France; Université Lille, Medicine School, Lille, France.
Gael PitonMedical Intensive Care Unit, CHRU Besançon, Besançon, France; EA3920, Université de Franche Comté, Besançon, France.
Jean-Pierre QuenotMedical-Surgical Intensive Care Unit, François Mitterrand University Hospital, Dijon, France; Lipness Team, INSERM UMR 866 and LabExLipSTIC, Université de Bourgogne, Dijon, France.
Jack RichecoeurMedical-Surgical Intensive Care Unit, Hôpital de Beauvais, Beauvais, France.
Jean-Philippe RigaudMedical-Surgical Intensive Care Unit, Hôpital de Dieppe, Dieppe, France.
René RobertMedical Intensive Care Unit, CHU Poitiers, Poitiers, France; Université de Poitiers, INSERM CIC1402, Poitiers, France.
Nathalie RolinMedical-Surgical Intensive Care Unit, Centre Hospitalier de Melun, Melun, France.
Carole SchwebelMedical Intensive Care Unit, CHU Albert Michallon Grenoble, Grenoble, France; Inserm U1039, Radiopharmaceutiques Biocliniques, Université Grenoble Alpes, La Tronche, France.
Michel SirodotMedical-Surgical Intensive Care Unit, Centre Hospitalier Annecy-Genevois, Metz-Tessy, Pringy, France.
François TinturierSurgical Intensive Care Unit, CHU Amiens Picardie, Amiens, France.
Didier ThéveninMedical-Surgical Intensive Care Unit, Centre Hospitalier Docteur Schaffner, Lens, France.
Bruno GiraudeauInserm CIC 1415, Tours, France; Université de Tours, Tours, France; CHU Tours, Tours, France; Université François-Rabelais de Tours, PRES Centre-Val de Loire Université, Tours, France.
Amélie Le GougeInserm CIC 1415, Tours, France; Université de Tours, Tours, France; CHU Tours, Tours, France.
NUTRIREA-2 Trial Investigators
Clinical Research in Intensive Care and Sepsis (CRICS) group
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier de Lens · FRCentre Hospitalier Universitaire de Tours · FRCentre Médical de La Teppe · FRHôpital Foch · FRHôpitaux Universitaires de Strasbourg · FRUniversité de Tours · FRCentre Hospitalier Annecy Genevois · FRCentre Hospitalier de Beauvais · FRCentre Hospitalier Départemental Vendée · FRCentre Hospitalier de Saint-Malo · FRCentre Hospitalier du Mans · FRCentre Hospitalier Intercommunal André Grégoire Montreuil · FRCentre Hospitalier Saint-Denis · FRCentre Hospitalier Universitaire de Besançon · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Saint-Étienne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhether the route of early feeding affects outcomes of patients with severe critical illnesses is controversial. We hypothesised that outcomes were better with early first-line enteral nutrition than with early first-line parenteral nutrition.

methodsIn this randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2 trial) done at 44 French intensive-care units (ICUs), adults (18 years or older) receiving invasive mechanical ventilation and vasopressor support for shock were randomly assigned (1:1) to either parenteral nutrition or enteral nutrition, both targeting normocaloric goals (20-25 kcal/kg per day), within 24 h after intubation. Randomisation was stratified by centre using permutation blocks of variable sizes. Given that route of nutrition cannot be masked, blinding of the physicians and nurses was not feasible. Patients receiving parenteral nutrition could be switched to enteral nutrition after at least 72 h in the event of shock resolution (no vasopressor support for 24 consecutive hours and arterial lactate <2 mmol/L). The primary endpoint was mortality on day 28 after randomisation in the intention-to-treat-population. This study is registered with ClinicalTrials.gov, number NCT01802099.

findingsAfter the second interim analysis, the independent Data Safety and Monitoring Board deemed that completing patient enrolment was unlikely to significantly change the results of the trial and recommended stopping patient recruitment. Between March 22, 2013, and June 30, 2015, 2410 patients were enrolled and randomly assigned; 1202 to the enteral group and 1208 to the parenteral group. By day 28, 443 (37%) of 1202 patients in the enteral group and 422 (35%) of 1208 patients in the parenteral group had died (absolute difference estimate 2·0%; [95% CI -1·9 to 5·8]; p=0·33). Cumulative incidence of patients with ICU-acquired infections did not differ between the enteral group (173 [14%]) and the parenteral group (194 [16%]; hazard ratio [HR] 0·89 [95% CI 0·72-1·09]; p=0·25). Compared with the parenteral group, the enteral group had higher cumulative incidences of patients with vomiting (406 [34%] vs 246 [20%]; HR 1·89 [1·62-2·20]; p<0·0001), diarrhoea (432 [36%] vs 393 [33%]; 1·20 [1·05-1·37]; p=0·009), bowel ischaemia (19 [2%] vs five [<1%]; 3·84 [1·43-10·3]; p=0·007), and acute colonic pseudo-obstruction (11 [1%] vs three [<1%]; 3·7 [1·03-13·2; p=0·04).

interpretationIn critically ill adults with shock, early isocaloric enteral nutrition did not reduce mortality or the risk of secondary infections but was associated with a greater risk of digestive complications compared with early isocaloric parenteral nutrition.

fundingLa Roche-sur-Yon Departmental Hospital and French Ministry of Health.

Indexed as

Critical CareEnteral NutritionParenteral NutritionRespiration, ArtificialAdultAgedFemaleHospital MortalityHumansLength of StayMaleMiddle AgedShockTime FactorsTreatment OutcomeVasoconstrictor AgentsVasoconstrictor Agents

Identifiers

PMID29128300
OpenAlexW2767390227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.